WHO ICTRP trial
A Study of Genz-112638 in Patients With Gaucher Disease (ENGAGE)
CTRI/2009/091/000689 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2009/091/000689 |
|---|---|
| Public title | A Study of Genz-112638 in Patients With Gaucher Disease (ENGAGE) |
| Scientific title | A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Confirming the Efficacy and Safety of Genz-112638 in Patients With Gaucher Disease Type 1 - ENGAGE |
| Primary sponsor | Genzyme Europe BV |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India;Bulgaria;Canada;Chile;Colombia;India;Israel;Jordan;Lebanon;Mexico;Netherlands;Russian Federation;Saudi Arabia;Tunisia;United Kingdom;United States of America |
| Conditions | Health Condition 1: null- Gaucher Disease Type 1 Health Condition 2: E752- Other sphingolipidosis |
| Interventions | Intervention1: Genz-112638: Capsule: 50, 100 or 150 mg BID Control Intervention1: Placebo: Capsule |
| Registration date | Dec 10, 2009 |
| Target size | 28 |
| Secondary IDs | 2008-005222-37;GZGD02507;NCT00891202 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: